Eric Schmidt

Eric Schmidt

Person

Heard in 92 episodes across 46 shows since Jan 2026

Eric Schmidt is an American technology executive, investor, and former Google chief executive and executive chairman. He has also advised governments and organizations on artificial intelligence, technology, and national security.

Discussed inMarkets32%Business29%AI & Tech21%Politics14%

Episodes

92
across 46 shows

This week

0
episodes on 0 shows

Guest appearances

3

Expert statements

8
8 negative

Share of the conversation

Mentions of Eric Schmidt per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.05‰0.1‰0.15‰0.2‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Oct 10.14‰3
Oct 20.16‰2
Oct 70.07‰3
Oct 90.03‰1
Oct 100.04‰1
Oct 120.06‰2
Oct 140.05‰2
Oct 150.06‰1
Oct 160.07‰2
Oct 170.09‰3
Oct 190.08‰1
Oct 200.13‰7
Oct 230.12‰3
Oct 260.09‰1
Oct 280.05‰2
Oct 300.03‰1
Nov 30.03‰1
Nov 40.03‰2
Nov 50.05‰2
Nov 60.06‰2
Nov 70.07‰1
Nov 100.07‰2
Nov 110.07‰1
Nov 130.07‰5
Nov 140.07‰1
Nov 160.09‰3
Nov 170.09‰1
Nov 190.09‰1
Nov 200.06‰1
Nov 210.06‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when Eric Schmidt comes up on a podcast

One email a week at most, with the new episodes that mention Eric Schmidt. Free, no account needed, unsubscribe in one click.

What Eric Schmidt has said on podcasts

9 statements

  1. on biotech sector de-grossingNegativeOct 23, 2026· Biotech Hangout

    Fund de-grossing may be materially affecting biotech sector performance.

    “this is the first time in the history of the industry that we've ever talked about this degrossing, having a very real and maybe tangible impact on the sector”

    Listen at 18:09

    Open the episode · Episode 200 - October 23, 2026
  2. on biotech valuationsNegativeOct 23, 2026· Biotech Hangout

    Structural trading dynamics may currently affect biotech valuations more than fundamentals.

    “the structural issues are potentially more of an impact than the fundamental issues”

    Listen at 19:01

    Open the episode · Episode 200 - October 23, 2026
  3. on Tango pancreatic-cancer PRMT5 inhibitorPositiveOct 23, 2026· Biotech Hangout

    Tango reported highly positive pancreatic-cancer data in refractory patients.

    “we just saw game-changing data, 82% response rate and 88% non-progression rate at nine months in very refractory third and fourth line pancreatic cancer patients”

    Listen at 49:03

    Open the episode · Episode 200 - October 23, 2026

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

What others have said about Eric Schmidt

8 statements · 8 negative

  1. Mike WarrenNegativeOct 2, 2026· The Dispatch Podcast

    The hearing evidence did not establish Schmidt’s alleged Atlanta Hawks meeting theory.

    “The evidence, however, wasn't actually there.”

    Listen at 7:22

    Open the episode · Sen. Schmitt’s Failed Attack on Jack Smith
  2. Mike WarrenNegativeOct 2, 2026· The Dispatch Podcast

    Eric Schmidt’s attempted gotcha failed and embarrassed him.

    “Eric Schmidt had a gotcha. that wasn't a gotcha at all and really kind of embarrassed himself.”

    Listen at 7:58

    Open the episode · Sen. Schmitt’s Failed Attack on Jack Smith
  3. Mike WarrenNegativeOct 2, 2026· The Dispatch Podcast

    Schmidt’s team relied only on text messages that did not support his claim.

    “literally the only piece of evidence that Schmidt and his team had were text messages that didn't say what he said that they said.”

    Listen at 14:30

    Open the episode · Sen. Schmitt’s Failed Attack on Jack Smith

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

92 episodes featuring Eric Schmidt, newest first

Works by Eric Schmidt

As an Amazon Associate, PodLume may earn from qualifying purchases.